CoChat

Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants

Mulet, Xavier, Maciá, María D., Mena, Ana, Juan, Carlos, Pérez, José L., Oliver, Antonio · 2009 · Antimicrobial Agents and Chemotherapy
Cited by 71

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Azithromycin (AZM) has shown promising results in the treatment of Pseudomonas aeruginosa chronic lung infections such as those occurring in cystic fibrosis (CF) patients. We evaluated the effect of hypermutation and alginate hyperproduction on the bactericidal activity and resistance development to AZM in P. aeruginosa biofilms. Strains PAO1, its mucA mutant (PAOMA), and their respective mutS -deficient hypermutable derivatives (PAOMS and PAOMSA) were used. Biofilms were incubated with several AZM concentrations for 1, 2, 4, or 7 days, and the numbers of viable cells were determined. During the first 2 days, AZM showed bactericidal activity for all the strains, but in extended AZM incubation for strain PAOMS and especially strain PAOMSA, a marked increased in the number of viable cells was observed, particularly at 4 μg/ml. Biofilms formed by the lineages recovered from the 7-day experiments showed enhanced AZM resistance. Furthermore, most of the independent lineages studied, including those obtained from biofilms treated with AZM concentrations as low as 0.5 μg/ml, showed MexCD-OprJ hyperexpression and mutations in nfxB . The role of nfxB mutation in AZM resistance was further confirmed through the characterization of nfxB and mexD knockout mutants. Results from this work show that, although AZM exhibits bactericidal activity against P. aeruginosa biofilms, resistant mutants are readily selected and that, furthermore, they frequently show cross-resistance to other unrelated antipseudomonal agents such as ciprofloxacin or cefepime but hypersusceptibility to others such as imipenem or tobramycin. Therefore, these results should help guide the selection of appropriate antipseudomonal therapies in CF patients under AZM maintenance treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.01264-08

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 45

  1. Bullock, W. O., J. M. Fernández, and J. M. Short. 1987. XL1 Blue: a high efficiency plasmid transforming recA Escherichia coli strain with β-galactosidase selection. BioTechniques5:376-378.
  2. 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
  3. 10.1126/science.284.5418.1318 · DOI · Paper page
  4. 10.1016/S0140-6736(02)11081-6 · DOI · Paper page
  5. 10.1128/JCM.42.12.5842-5845.2004 · DOI
  6. 10.1128/AAC.49.9.3858-3867.2005 · DOI · Paper page
  7. 10.1128/mr.60.3.539-574.1996 · doi:10.1128/mr.60.3.539-574.1996 · Paper page
  8. 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
  9. 10.1128/AAC.42.4.974 · DOI · Paper page
  10. 10.1128/AAC.00148-07 · DOI · Paper page
  11. 10.1016/S0924-8579(03)00009-8 · DOI
  12. 10.1128/AAC.31.4.582 · DOI · Paper page
  13. 10.1128/AAC.01011-06 · DOI · Paper page
  14. 10.1016/S1286-4579(00)01349-6 · DOI · Paper page
  15. 10.1159/000239440 · DOI · Paper page
  16. 10.1128/AAC.49.4.1377-1380.2005 · DOI
  17. 10.1128/AAC.36.11.2562 · DOI · Paper page
  18. 10.1128/AAC.44.3.710-712.2000 · DOI · Paper page
  19. 10.1128/AAC.01107-07 · DOI · Paper page
  20. 10.1128/AAC.00613-07 · DOI · Paper page
  21. 10.1128/JB.183.18.5213-5222.2001 · DOI · Paper page
  22. 10.1128/JB.187.4.1384-1391.2005 · DOI · Paper page
  23. 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
  24. 10.1128/AAC.50.3.975-983.2006 · DOI
  25. 10.2144/02335rr01 · DOI · Paper page
  26. 10.1128/AAC.40.4.909 · doi:10.1128/aac.40.4.909
  27. 10.1128/JB.00120-07 · DOI
  28. 10.1128/JCM.42.5.1915-1922.2004 · DOI · Paper page
  29. 10.1128/AAC.50.5.1680-1688.2006 · DOI · Paper page
  30. Oh, H., S. Stenhoff, S. Jalal, and B. Wretlind. 2003. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb. Drug Res.8:323-328.
  31. 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
  32. 10.1126/science.288.5469.1251 · DOI · Paper page
  33. 10.1128/AAC.48.11.4226-4233.2004 · DOI
  34. Oliver, A. M., and D. M. Weir. 1985. The effect of Pseudomonas aeruginosa alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. Clin. Exp. Immunol.59:190-196.
  35. 10.1128/IAI.67.9.4744-4750.1999 · DOI
  36. 10.1128/iai.58.10.3363-3368.1990 · DOI · Paper page
  37. 10.1128/AAC.00174-07 · DOI
  38. 10.2144/05381ST01 · DOI
  39. 10.1038/nbt1183-784 · DOI · Paper page
  40. 10.1016/0891-5849(89)90078-6 · DOI · Paper page
  41. 10.1093/nar/17.24.10509 · DOI · Paper page
  42. 10.1038/35023079 · DOI · Paper page
  43. 10.1128/AAC.45.6.1930-1933.2001 · DOI
  44. 10.1007/s101560050042 · doi:10.1007/s101560050042
  45. 10.1136/thorax.57.3.212 · DOI · Paper page

Cited by

See all 71

Metadata

Authors
Mulet, X., Maciá, M. D., Mena, A., Juan, C., Pérez, J. L., & Oliver, A.
Affiliations
Servicio de Microbiología and Unidad de Investigación, Hospital Son Dureta, Instituto Universitario de Investigación en Ciencias de la Salud, Palma de Mallorca, Spain
Venue
Antimicrobial Agents and Chemotherapy
Published
2009-04
Volume
53
Issue
4
Pages
1552-1560
ISSN
  • 0066-4804
  • 1098-6596
Cited by
71
References
1
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants. https://app.cochat.ai/papers/10.1128/aac.01264-08
The paper
Mulet, X., Maciá, M. D., Mena, A., Juan, C., Pérez, J. L., & Oliver, A. (2009). Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01264-08

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.